Stay updated on Safety & Metabolic Profile of Vyvanse in ADHD & Bipolar Adults Clinical Trial
Sign up to get notified when there's something new on the Safety & Metabolic Profile of Vyvanse in ADHD & Bipolar Adults Clinical Trial page.

Latest updates to the Safety & Metabolic Profile of Vyvanse in ADHD & Bipolar Adults Clinical Trial page
- Check2 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a note regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.SummaryDifference2%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check66 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check80 days agoChange DetectedThe page has been updated to include new information about Attention Deficit/Hyperactivity Disorder (ADHD) and the medication Vyvanse, while significant details regarding the implications of adult ADHD have been removed.SummaryDifference29%
Stay in the know with updates to Safety & Metabolic Profile of Vyvanse in ADHD & Bipolar Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Metabolic Profile of Vyvanse in ADHD & Bipolar Adults Clinical Trial page.